Terms: = Endocrine gland cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA
251 results:
1. Application of interpretable machine learning algorithms to predict distant metastasis in ovarian clear cell carcinoma.
Guo QH; Xie FC; Zhong FM; Wen W; Zhang XR; Yu XJ; Wang XL; Huang B; Li LP; Wang XZ
Cancer Med; 2024 Apr; 13(7):e7161. PubMed ID: 38613173
[TBL] [Abstract] [Full Text] [Related]
2. [Ultrasonographic features of thyroid carcinoma of different sizes: comparison between medullary thyroid carcinomas and papillary thyroid carcinomas].
Zhang D; Yang F; Wang Y; Mu JL; Wei XQ; Wei X
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):133-139. PubMed ID: 38418187
[No Abstract] [Full Text] [Related]
3. Association between Endometriosis and the Risk of Ovarian, Endometrial, Cervical, and Breast cancer: A Population-Based Study from the U.S. National Inpatient Sample 2016-2019.
Al-Badawi IA; Abu-Zaid A; Alomar O; Alsabban M; Alsehaimi SO; Alqarni SMS; Alabdrabalamir SN; Baradwan S; Al Baalharith M; AlOdaini AA; Saleh SAK; Adly HM; Bukhari IA; Salem H
Curr Oncol; 2024 Jan; 31(1):472-481. PubMed ID: 38248117
[TBL] [Abstract] [Full Text] [Related]
4. A diagnostic model based on DNA methylation haplotype block characteristics for identifying papillary thyroid carcinoma from thyroid adenoma.
Xu D; Lai Y; Liu H; Li H; Feng N; Liu Y; Gong C; Zhang Y; Zhou J; Shen Y
Transl Res; 2024 Feb; 264():76-84. PubMed ID: 37863284
[TBL] [Abstract] [Full Text] [Related]
5. Low Prognostic Nutritional Index Is Common and Associated with Poor Outcomes following Curative-Intent Resection for Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Xiang JX; Qian YR; He J; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Lv Y; Zhang XF; Pawlik TM
Neuroendocrinology; 2024; 114(2):158-169. PubMed ID: 37703840
[TBL] [Abstract] [Full Text] [Related]
6. Causal associations between thyroid cancer and iga nephropathy: a Mendelian randomization study.
Mei Z; Li F; Chen R; Xiao Z; Cai D; Jin L; Qian X; Wang Y; Chen J
BMC Genomics; 2023 Sep; 24(1):525. PubMed ID: 37670254
[TBL] [Abstract] [Full Text] [Related]
7. Association between contralateral adrenal and hypothalamus-pituitary-adrenal axis in benign adrenocortical tumors.
Zhu H; Wu L; Su T; Jiang L; Zhou W; Jiang Y; Zhang C; Zhong X; Wang W
Front Endocrinol (Lausanne); 2023; 14():1199875. PubMed ID: 37560307
[TBL] [Abstract] [Full Text] [Related]
8. TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer.
Zorea J; Motro Y; Mazor RD; Carmi YK; Shulman Z; Mahajna J; Moran-Gilad J; Elkabets M
J Exp Clin Cancer Res; 2023 May; 42(1):107. PubMed ID: 37121997
[TBL] [Abstract] [Full Text] [Related]
9. Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma.
Handley KF; Mehta S; Martin AL; Biswas S; Maharaj K; Nagy MZ; Mine JA; Cortina C; Yu X; Sprenger K; Mandal G; Innamarato P; Powers JJ; Harro CM; Chaurio RA; Anadon CM; Shahzad MM; Flores I; Conejo-Garcia JR
Gynecol Oncol; 2023 Jun; 173():114-121. PubMed ID: 37121178
[TBL] [Abstract] [Full Text] [Related]
10. Pancreatic cancer is associated with medication changes prior to clinical diagnosis.
Zhang Y; Wang QL; Yuan C; Lee AA; Babic A; Ng K; Perez K; Nowak JA; Lagergren J; Stampfer MJ; Giovannucci EL; Sander C; Rosenthal MH; Kraft P; Wolpin BM
Nat Commun; 2023 Apr; 14(1):2437. PubMed ID: 37117188
[TBL] [Abstract] [Full Text] [Related]
11. Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the cancer-VTE Registry.
Ohsumi S; Watanabe K; Kondo N; Kosaka Y; Ishikawa T; Kitahara M; Kubo S; Oba MS; Kimura T; Takita A; Mukai H
Breast Cancer; 2023 Jul; 30(4):607-616. PubMed ID: 37069366
[TBL] [Abstract] [Full Text] [Related]
12. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; ; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón Y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido Dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U; Modugno F; Pharoah PD; Schildkraut JM; Sieh W; Staebler A; Sundfeldt K; Swerdlow AJ; Ramus SJ; Brenton JD
J Pathol Clin Res; 2023 May; 9(3):208-222. PubMed ID: 36948887
[TBL] [Abstract] [Full Text] [Related]
13. The risk of central nodal metastasis based on prognostic factors of the differentiated thyroid carcinoma: a systematic review and meta-analysis study.
Hafez LG; Elkomos BE; El-Shafaei MAM; Omran HMA; Saad AS
Eur Arch Otorhinolaryngol; 2023 Jun; 280(6):2675-2686. PubMed ID: 36759363
[TBL] [Abstract] [Full Text] [Related]
14. Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma.
Xiao R; Ni C; Cai Y; Zhou Y; Gong X; Xie K; You J
Endocrine; 2023 Jun; 80(3):619-629. PubMed ID: 36696026
[TBL] [Abstract] [Full Text] [Related]
15. Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy.
Ju Y; Wang L; Cheng F; Huang F; Chen X; Song Q; Xiao J; Zhu X; Jia H
BMC Endocr Disord; 2023 Jan; 23(1):19. PubMed ID: 36670396
[TBL] [Abstract] [Full Text] [Related]
16. Peripheral and tumor-infiltrating immune cells are correlated with patient outcomes in ovarian cancer.
Zhang W; Ling Y; Li Z; Peng X; Ren Y
Cancer Med; 2023 Apr; 12(8):10045-10061. PubMed ID: 36645174
[TBL] [Abstract] [Full Text] [Related]
17. Fully automatic volume measurement of the adrenal gland on CT using deep learning to classify adrenal hyperplasia.
Kim TM; Choi SJ; Ko JY; Kim S; Jeong CW; Cho JY; Kim SY; Kim YG
Eur Radiol; 2023 Jun; 33(6):4292-4302. PubMed ID: 36571602
[TBL] [Abstract] [Full Text] [Related]
18. Risk prediction model establishment with tri-phasic CT image features for differential diagnosis of adrenal pheochromocytomas and lipid-poor adenomas: Grouping method.
Niu Z; Wang J; Yang Y; He J; Wang S; Xie Z; Shao M; Zhu F
Front Endocrinol (Lausanne); 2022; 13():925577. PubMed ID: 36568104
[TBL] [Abstract] [Full Text] [Related]
19. Adjuvant
Tempero MA; Pelzer U; O'Reilly EM; Winter J; Oh DY; Li CP; Tortora G; Chang HM; Lopez CD; Bekaii-Saab T; Ko AH; Santoro A; Park JO; Noel MS; Frassineti GL; Shan YS; Dean A; Riess H; Van Cutsem E; Berlin J; Philip P; Moore M; Goldstein D; Tabernero J; Li M; Ferrara S; Le Bruchec Y; Zhang G; Lu B; Biankin AV; Reni M;
J Clin Oncol; 2023 Apr; 41(11):2007-2019. PubMed ID: 36521097
[TBL] [Abstract] [Full Text] [Related]
20. Classification prediction of pancreatic cystic neoplasms based on radiomics deep learning models.
Liang W; Tian W; Wang Y; Wang P; Wang Y; Zhang H; Ruan S; Shao J; Zhang X; Huang D; Ding Y; Bai X
BMC Cancer; 2022 Nov; 22(1):1237. PubMed ID: 36447168
[TBL] [Abstract] [Full Text] [Related]
[Next]
